Company intelligence / Profile preview

Cantrell Drug Company

Little Rock, Arkansas, United Statesfda.gov ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Cantrell Drug Company specializes in providing FDA-compliant sterile injectable pharmaceuticals and compounded preparations to hospitals nationwide. It has produced over 400 unique formulations addressing critical drug shortages. The company has implemented advanced quality systems including rapid microbiological sterility testing and automated closed vial filling technology. In late 2017 it entered Chapter 11 bankruptcy but continued operations at that time[1][2][5].

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Kymanox/Kynamox for quality remediation consulting after FDA observations in 2017

Beyond the preview

Go deeper on Cantrell Drug Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cantrell Drug Company.

Explore the full profile